Swedish Orphan Biovitrum (Sobi)

Sobi is an international specialty healthcare company dedicated to rare diseases. Our mission is to develop and deliver innovative therapies and services to improve the lives of patients. Sobi has a long tradition in haemophilia, which currently includes two late-stage biological treatments in development. We re-join the haemophilia community with commitment that drives us towards innovations in treatment of haemophilia with the simple goal to provide people with haemophilia choices that help them to live the lives they wish for.